Geode Capital Management
RYZB

Geode Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Geode Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-434,891
Closed -$27M – 4686
2023
Q4 		$27M Buy
434,891
+390,406
+878% +$9.7M ﹤0.01% 1728
2023
Q3 		$988K Buy
+44,485
New +$934K ﹤0.01% 3324

Geode Capital Management's RYZB Position: Q1 2024 in Review

Geode Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 434,891 shares — an estimated $27M sold.

Geode Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $27M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Geode Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 434,891 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $27M.
  • Geode Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Geode Capital Management's RayzeBio, Inc. Common Stock position peaked at $27M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.